Figure 4From: Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C Galbraith plot. Detection of studies acting as possible sources of heterogeneity for rs12979860 and rs8099917 for sustained virologic response (SVR). Trials outside the Galbraith limits were trials where the 95% confidence interval did not contain the pooled estimate.Back to article page